2005
DOI: 10.1016/j.jconrel.2005.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 36 publications
0
17
0
1
Order By: Relevance
“…Additionally, drugs that inhibit GAG synthesis have been used to reduce the thickness of the layer [11]. Alternatively, glycosaminoglycan drug carriers have been shown to be taken up into GAG layers, increasing penetration of drug into tumour interstitium [12,13]. GAG has also been considered a barrier to effective therapy with the immunotherapeutic drug BCG [14].…”
Section: Glycosaminoglycans Present a Barrier To Drug Penetrationmentioning
confidence: 99%
“…Additionally, drugs that inhibit GAG synthesis have been used to reduce the thickness of the layer [11]. Alternatively, glycosaminoglycan drug carriers have been shown to be taken up into GAG layers, increasing penetration of drug into tumour interstitium [12,13]. GAG has also been considered a barrier to effective therapy with the immunotherapeutic drug BCG [14].…”
Section: Glycosaminoglycans Present a Barrier To Drug Penetrationmentioning
confidence: 99%
“…It has been shown in certain cancer xenografts that the outer rim of the tumor is better perfused than the central region. 27,[38][39][40] Utilizing MRI and redox scanning, our melanoma studies demonstrated a distinct core-rim difference both for the blood transfer constant ͑K trans ͒ measured by dynamic contrast enhancement MRI ͑DCE-MRI͒ and the mitochondrial redox state measured by low-temperature NADH/Fp fluorescence. 27 The more aggressive melanoma line appears to have a tumor core with less blood perfusion, lower nutrient supply, and a more oxidized redox state.…”
Section: Possible Metabolic States In Tumorsmentioning
confidence: 99%
“…5 Despite their potential as a targeted drug delivery system, nanoparticles made of PLG/PLA or mPEG-PLGA/ mPEG-PLA have limited capability for encapsulating water soluble drugs, including therapeutic peptides, due to the large surface area, hydrophobic nature of PLGA/PLA, their chemical properties, and methods of production. To overcome these shortcomings, various strategies have been developed, such as the use of drug complexation agents, 6 complexation with phospholipids, 7 and inclusion of ion-paring agents in the formulation, 8 all of which are designed to improve the incorporation of drug and peptide into these polymeric nanoparticles.…”
Section: Introductionmentioning
confidence: 99%